McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN. Schistosomiasis. Nat Rev Dis Primers. 2018;4(1):13.
Xia S, Xue JB, Zhang X, Hu HH, Abe EM, Rollinson D, et al. Pattern analysis of schistosomiasis prevalence by exploring predictive modeling in Jiangling County, Hubei Province, PR China. Infected Dis Poverty. 2017;6(1):91.
Li C, Ren G, Deng W, Li S, Hu B, Shi Y, et al. Prevalence and incidence of advanced schistosomiasis and risk factors for case fatality in Hunan Province, China. Acta Trop. 2021;217:105862.
Jiang H, Deng W, Zhou J, Ren G, Cai X, Li S, et al. Machine learning algorithms to predict the 1 year unfavorable prognosis for advanced schistosomiasis. Int J Parasitol. 2021;51(11):959–65.
Wu XH, Wang TP, Lu DB, Hu HT, Gao ZB, Zhu CG, et al. Studies of impact on physical fitness and working capacity of patients with advanced Schistosomiasis japonica in Susong County, Anhui Province. Acta Trop. 2002;82(2):247–52.
Liao HB. Effect of clinical pathway on advanced schistosomiasis patients with acites: a report of 220 cases. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2015;27(3):319–20 (in Chinese).
Google Scholar
Li YS, Yu DB, Li Y, Yuan LP, Xiang Y, Zhao XG, et al. A study and analysis of the deaths due to advanced Schistosoma-Japonicum infection in the Dongting Lake Area of China. J Trop Med Hyg. 1993;96(2):128–30.
Huang D, Ma X, Fau-Cai L, Cai L. Evaluation of the effect of causes of death of advanced schistosomiasis patients on the life span of population by using potential years of life lost analysis. Chinese J Parasitol Parasitic Dis. 1998;16(6):449–53 (in Chinese).
Zhou Y, Chen Y, Jiang Q. History of Human Schistosomiasis (bilharziasis) in China: from discovery to elimination. Acta Parasitol. 2021;66(3):760–9.
Wu YZ, Sun GX, Gui FC, Cheng HR, Qian M, Xu DY, et al. Analysis of life span and death causes of advanced schistosomiasis patients in different control stages. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 1996;8(5):289 (in Chinese).
Google Scholar
Song L, Wu X, Ren J, Gao Z, Xu Y, Xie H, et al. Assessment of the effect of treatment and assistance program on advanced patients with schistosomiasis japonica in China from 2009 to 2014. Parasitol Res. 2016;115(11):4267–73.
Li FY, Tan HZ, Zhou J, Zhou RH, Zhu JH, Cai XT, et al. Analysis of characteristics of medical assistance to advanced schistosomiasis patients in Hunan Province, 2015. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2017;29(3):281–5 (in Chinese).
Google Scholar
Zhang LJ, Xu ZM, Dang H, Li YL, Lu S, Xu J, et al. Endemic status of schistosomiasis in the People’s Republic of China in 2019. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2020;32(6):551–8 (in Chinese).
Zheng Y, Chang Q, Yip PSF. Understanding the increase in life expectancy in Hong Kong: contributions of changes in age- and cause-specific mortality. Int J Environ Heal R. 2019;16(11):1959.
Google Scholar
Yu SL, Luo DF, Yin P, Yang PN, Xiang HY, Wang S. Analysis of life expectancy of patients with advanced schistosomiasis. Chinese J Health Static. 1992;9(4):51–3 (in Chinese).
Google Scholar
Vaupel JW. How change in age-specific mortality affects life expectancy. Pop Stud-J Demog. 1986;40(1):147–57.
Li YT, Cai XT, Zhu JH, Sun LP, Hua HY, Tian LG, et al. Approaches used for assessment of the burden of advanced schistosomiasis japonica: a comparative study. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2019;31(3):280–4 (in Chinese).
Google Scholar
Wu LL, Hu HH, Zhang X, Zhou XN, Jia TW, Wang C, et al. Cost-effectiveness analysis of the integrated control strategy for schistosomiasis japonica in a lake region of China: a case study. Infected Dis Poverty. 2021;10(1):79.
Zhang Z, Dong J, Zhao C, Li Q. Trends of healthy life expectancy of the elderly in China in 1994–2015: revisiting from the perspective of morbidity transition. Front Public Health. 2021;9:774205.
Deng WC, Bai DH, Li ZJ, He Y, Deng Y, Zhu YH, et al. Management strategy and technology of medical assistance to advanced schistosomiasis patients in Hunan Province. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2016;28(5):594–5 (in Chinese).
Google Scholar
Zhang LJ, Li SZ, Wen LY, Lin DD, Abe EM, Zhu R, et al. The establishment and function of schistosomiasis surveillance system towards elimination in The People’s Republic of China. Adv Parasitol. 2016;92:117–41.
Li GP, Yu XL, Wu X, Zhao ZY, Xia M, Deng Y, et al. Endemic situation of schistosomiasis in national surveillance sites of Hunan Province from 2015 to 2019. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2020;32(3):242–7 (in Chinese).
Preston S, Heuveline P, Demography GM. Measuring and modeling population processes. Oxford: Blackwell Publishers; 2001.p. 320.
Google Scholar
Arriaga EE. Measuring and explaining the changes in life expectancies. Demographics. 1984;21(1):83–96.
Pollard JH. On the decomposition of changes in expectations of life and differentials in life expectancy. Demographics. 1988;25(2):265–76.
Andreev E, Shkolnikov VM, Begun AZ. Algorithm for decomposition of differences between aggregate demographic measures and its application to life expectancies, healthy life expectancies, parity progression ratios and total fertility rates. Demogr Res. 2002;7:499–522.
Jung-Choi K, Khang YH, Cho HJ, Yun SC. Decomposition of educational differences in life expectancy by age and causes of death among South Korean adults. BMC Public Health. 2014;14:560.
Sullivan DF. A single index of mortality and morbidity. HSMHA Health Rep. 1971;86(4):347–54.
Sole-Auro A, Martin U, Rodriguez AD. Educational inequalities in life and healthy life expectancies among the 50-plus in Spain. Int J Env Res Pub He. 2020;17(10):3558.
Noh E, Kang HY, Bahk J, Kim I, Khang YH. Cancer-free life expectancy in small administrative areas in Korea and its associations with regional health insurance premiums. J Korean Med Sci. 2021;36(42): e269.
Nielsen CR, Ahrenfeldt LJ, Jeune B, Christensen K, Lindahl-Jacobsen R. Healthy life expectancy by frailty state in Europe from 2004 to 2015: findings from SHARE. EuroJ Public Health. 2021;31(3):554–60.
Jia TW, Utzinger J, Deng Y, Yang K, Li YY, Zhu JH, et al. Quantifying quality of life and disability of patients with advanced schistosomiasis japonica. PLoS Negl Trop Dis. 2011;5(2): e966.
Yang F, Xu J, Lu S, Cao CL, Li SZ, Zhang LJ. Analysis on epidemiological characteristics of current advanced schistosomiasis cases in China based on the epidemiological dynamic data collection platform (EDDC). Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2021;33(3):234–9 (in Chinese).
Li GF, Teng Z, Tian JG, Yu X, Yu XQ, Sun XD. Quality of life and its influencing factors of advanced schistosomiasis patients in Qingpu District, Shanghai. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2014;26(3):303–7 (in Chinese).
Google Scholar
Nie YX. Depression prevalence and quality of life of patients with advanced schistosomiasis. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2011;23(5):579–81 (in Chinese).
Google Scholar
Le Y, Ren J, Shen J, Li T, Zhang CF. The changing gender differences in life expectancy in Chinese cities 2005–2010. PLOS ONE. 2015;10(4): e0123320.
Chen H, Qian Y, Dong YQ, Yang ZJ, Guo LL, Liu J, et al. Analysis of gender differences in life expectancy of Chinese residents in 1990 and 2017. Chinese J Health Stasis. 2020;37(06):883–7 (in Chinese).
Google Scholar
Borah G. Gender gap in life expectancy in India and role of age groups: a comparison between before and after male–female life expectancy at birth crossover. PLOS ONE. 2021;16(12): e0260657.
Pan XF, Li Y, Franco OH, Yuan JM, Pan A, Koh WP. Impact of combined lifestyle factors on all-cause and cause-specific mortality and life expectancy in China: The Singapore Chinese Health Study. J Gerontol A Biol Sci Med Sci. 2020;75(11):2193–9.
Sun Q, Yu D, Fan J, Yu C, Guo Y, Pei P, et al. Healthy lifestyle and life expectancy at age 30 years in the Chinese population: an observational study. Lancet Public Health. 2022;7(12):e994–1004.
Lackner C, Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol. 2019;70(2):294–304.
Zein CO, Unalp A, Colvin R, Liu YC, McCullough AJ. Nonalcoholic steatohepatitis clinical research N. smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol. 2011;54(4):753–9.
Liu Y, Yuan HC, Lin DD, Liu YM, Hu F, Zhao GM, et al. Studies on risk factors for liver fibrosis of schistosomiasis japonica. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2000;18(1):18–20 (in Chinese).